Biggest News Aggregation in the World
📰 Segments Profiled News

Page 29 - Segments Profiled News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.

Gastrointestinal Stromal Tumor Therapeutics Market to Register 6% CAGR in 2023 to 2033

During the forecast period 2023 to 2033, the Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Gastrointestinal stromal tumor (GIST) therapeutics is expected to rise up to a market valuatio...
New York United States Asia Pacific Bristol Myers Squibb Arog Pharmaceuticals Cogent Biosciences Inc

Hand Eczema Treatment Market is expected to grow with a 8% CAGR through 2033

The global Hand Eczema (HE) Treatment Market is predicted to generate a market value of US$ 53 Million in 2023 and a market value of US$ 114.42 Million by 2033, with a CAGR of 8% from 2023 to 2033. In the historical period 2018 to 2022, the market for Hand Eczema (HE) Treatment grew at a CAGR of 4%.According to Stud...
New York United States Asia Pacific Healthcare Division At Future Market Insights Market Insights Inc Greater New York Chamber

Migraine Treatment Market is expected to grow with a 4% CAGR during 2023 to 2033

The global Migraine Treatment Market is predicted to generate a market value of US$ 3.2 billion in 2023 and a market value of US$ 4.74 billion by 2033, with a CAGR of 4% from 2023 to 2033. In the historical period 2018 to 2022, the Migraine Therapy market grew at a CAGR of 3%.The condition is characterized by severe...
New York United States Eli Lilly Zosano Pharma University College London Biohaven Pharmaceuticals

Hematopoietic Stem Cell Transplantation to Hog Limelight in Europe from 2023 to 2033 | FMI Foresees

As per the report published by Future Market Insights (FMI), the Hematopoietic Stem Cell Transplantation (HSCT) market in Europe is projected to accelerate at a CAGR of 7.6% from 2023 to 2033.Leukemia and lymphoproliferative disorders are among the most common types of medical conditions in Europe and reported cases...
New York United States Jazz Pharmaceuticals European Hematology Association Jasper Therapeutics Inc Hematopoietic Stem Cell Transplantation Market Industry

Europe Balloon Catheter Market to Witness Billion $ Opportunity Amid Rising Prevalence of Peripheral

The United Kingdom Balloon Catheter Market is expected to reach a total of US$ 273.4 million by 2033, and likely to expand at a steady CAGR of 4.8% from 2023 to 2033. Germany balloon catheter market is also set to expand at a steady 4.7% CAGR, and the sales of balloon catheter is anticipated to generate a market val...
New York United States United Kingdom Biosense Webster Inc Surgical Centers Sample Of Research

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Nipah Virus Infection Testing Market is expected to grow with a 5.2% CAGR from 2023 to 2033

During the forecast period 2023 to 2033, the Nipah virus (NiV) infection testing market is expected to grow at a value of 5.2% CAGR, according to Future Market Insights. By the year 2033, the global market for Nipah virus (NiV) infection testing is expected to rise up to a market valuation of US$ 3.277.49 million. T...
New York United States Starlake Bioscience Krishgen Biosystems Asia Pacific Market Insights Inc

Hidradenitis Suppurative (HS) Treatment Market is projected to reach US$ 1,240.9 million by 2033

The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023 and is projected to reach US$ 1,240.9 million by 2033, growing at a CAGR of 4.97%. Hidradenitis suppurativa market is currently having vast pipeline therapies targeting interleukins,...
New York United States United Arab Emirates Hidradenitis Suppurativa Hs Treatment Market Industry Greater New York Chamber Abbvie Inc

Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million

The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of6% in the forecast period 2023-2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in t...
New York United States United Arab Emirates Asia Pacific Eli Lilly Zealand Pharma

Hyperpigmentation Treatment Market to expand at a 8.6% value CAGR by 2033

The global hyperpigmentation treatment market is predicted to be worth $4.78 billion in 2023, with a compound yearly growth rate (CAGR) of 8.6% projected from 2023 to 2033. Skin hyperpigmentation results from a slight decrease in melanin synthesis. Laser treatment, cosmeceuticals, and chemical peels can all be used...
New York United States France General La Roche Posay Poitou Charentes Vivier Pharma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science